| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 10, 488-498, Copyright © 1996 by Endocrine Society
ARTICLES |
JS Foster and J Wimalasena
Department of Obstetrics and Gynecology, University of Tennessee Medical Center, Knoxville 37920, USA.
Cyclin-dependent kinases (Cdk) act to regulate G1- to S-phase transition in mammalian cells. We have studied the effects of estradiol and the steroidal antiestrogen ICI 182, 780 on induction of Cdk activity and the consequent phosphorylation of retinoblastoma protein (Rb) in estrogen-responsive MCF-7 breast cancer cells. Treatment of growth-arrested MCF-7 cells with physiological concentrations of estradiol led to a time-dependent increase in Cdk2-associated and cyclin E-dependent kinase activity, which was accompanied by hyperphosphorylation of Rb and S-phase entry. Induction of both Cdk2 activity and DNA synthesis by estradiol was dose dependent and was inhibited by coadministration of ICI 182,780. Elicitation of Cdk2 activity was found to require prolonged (> 8h) estradiol exposure. Levels of cyclins E and A were unchanged in MCF-7 cells undergoing G1- to S-transit; however, synthesis and steady state levels of cyclin D1 protein were increased by estradiol. Cdk4-associated Rb kinase activity was evident in MCF-7 cells by 6 h after estradiol exposure and was inhibited by antiestrogen. Cdk2 and Cdk4 protein levels were not altered by estrogen treatment; however, faster migrating, phosphorylated Cdk2 forms increased in estradiol-treated MCF-7 cells by 12 after release from growth arrest. Cdtk-inhibitory activities, associated with p27kip-1, were eliminated from growth-arrested MCF-7 cells after treatment with estradiol but were not eliminated from cells cotreated with estradiol and ICI 182,780. These findings suggest that estradiol regulates G1 progression in MCF-7 cells through direct effects upon Cdk activation, Rb phosphorylation, and by inducing elimination of Cdk inhibitors.
This article has been cited by other articles:
![]() |
H. Kim, K. Heo, J. H. Kim, K. Kim, J. Choi, and W. An Requirement of Histone Methyltransferase SMYD3 for Estrogen Receptor-mediated Transcription J. Biol. Chem., July 24, 2009; 284(30): 19867 - 19877. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Huang, T.-D. Way, C.-L. Lin, and J.-K. Lin EGCG Stabilizes p27kip1 in E2-Stimulated MCF-7 Cells through Down-Regulation of the Skp2 Protein Endocrinology, December 1, 2008; 149(12): 5972 - 5983. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Renoir, C. Bouclier, A. Seguin, V. Marsaud, and B. Sola Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cells J. Mol. Endocrinol., March 1, 2008; 40(3): 101 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fernando, J. S. Foster, A. Bible, A. Strom, R. G. Pestell, M. Rao, A. Saxton, S. J. Baek, K. Yamaguchi, R. Donnell, et al. Breast Cancer Cell Proliferation Is Inhibited by BAD: REGULATION OF CYCLIN D1 J. Biol. Chem., September 28, 2007; 282(39): 28864 - 28873. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. den Hollander, S. K. Rayala, D. Coverley, and R. Kumar Ciz1, a Novel DNA-Binding Coactivator of the Estrogen Receptor {alpha}, Confers Hypersensitivity to Estrogen Action. Cancer Res., November 15, 2006; 66(22): 11021 - 11029. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lupu and J. A. Menendez Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators? Endocrinology, September 1, 2006; 147(9): 4056 - 4066. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. den Hollander and R. Kumar Dynein Light Chain 1 Contributes to Cell Cycle Progression by Increasing Cyclin-Dependent Kinase 2 Activity in Estrogen-Stimulated Cells Cancer Res., June 1, 2006; 66(11): 5941 - 5949. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Tu, S. Prajapati, K.-J. Park, N. J. Kelly, Y. Yamamoto, and R. B. Gaynor IKK{alpha} Regulates Estrogen-induced Cell Cycle Progression by Modulating E2F1 Expression J. Biol. Chem., March 10, 2006; 281(10): 6699 - 6706. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.J. Weroha, S. A. Li, O. Tawfik, and J. J. Li Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats Carcinogenesis, March 1, 2006; 27(3): 491 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J Butt, C. M McNeil, E. A Musgrove, and R. L Sutherland Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E Endocr. Relat. Cancer, July 1, 2005; 12(Supplement_1): S47 - S59. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. G. Rodriguez-Mora, M. M. LaHair, J. A. McCubrey, and R. A. Franklin Calcium/Calmodulin-Dependent Kinase I and Calcium/Calmodulin-Dependent Kinase Kinase Participate in the Control of Cell Cycle Progression in MCF-7 Human Breast Cancer Cells Cancer Res., June 15, 2005; 65(12): 5408 - 5416. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Albrecht, G. W. Aberdeen, and G. J. Pepe Estrogen Elicits Cortical Zone-Specific Effects on Development of the Primate Fetal Adrenal Gland Endocrinology, April 1, 2005; 146(4): 1737 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S Lewis, T J Thomas, R. G Pestell, C. Albanese, M. A Gallo, and T. Thomas Differential effects of 16{alpha}-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells J. Mol. Endocrinol., February 1, 2005; 34(1): 91 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Hilakivi-Clarke, C Wang, M Kalil, R Riggins, and R G Pestell Nutritional modulation of the cell cycle and breast cancer Endocr. Relat. Cancer, December 1, 2004; 11(4): 603 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Lauber, S. Ali, and N. J. Gooderham The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity Carcinogenesis, December 1, 2004; 25(12): 2509 - 2517. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Fernando and J. Wimalasena Estradiol Abrogates Apoptosis in Breast Cancer Cells through Inactivation of BAD: Ras-dependent Nongenomic Pathways Requiring Signaling through ERK and Akt Mol. Biol. Cell, July 1, 2004; 15(7): 3266 - 3284. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-C. Chen and S. M. Donovan Genistein at a Concentration Present in Soy Infant Formula Inhibits Caco-2BBe Cell Proliferation by Causing G2/M Cell Cycle Arrest J. Nutr., June 1, 2004; 134(6): 1303 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cabodi, L. Moro, G. Baj, M. Smeriglio, P. Di Stefano, S. Gippone, N. Surico, L. Silengo, E. Turco, G. Tarone, et al. p130Cas interacts with estrogen receptor {alpha} and modulates non-genomic estrogen signaling in breast cancer cells J. Cell Sci., March 15, 2004; 117(8): 1603 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strom, J. Hartman, J. S. Foster, S. Kietz, J. Wimalasena, and J.-A. Gustafsson Estrogen receptor {beta} inhibits 17{beta}-estradiol-stimulated proliferation of the breast cancer cell line T47D PNAS, February 10, 2004; 101(6): 1566 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Foster, R. I. Fernando, N. Ishida, K. I. Nakayama, and J. Wimalasena Estrogens Down-regulate p27Kip1 in Breast Cancer Cells through Skp2 and through Nuclear Export Mediated by the ERK Pathway J. Biol. Chem., October 17, 2003; 278(42): 41355 - 41366. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lu, A. Pierron, and K. Ravid An Adenosine Analogue, IB-MECA, Down-Regulates Estrogen Receptor {alpha} and Suppresses Human Breast Cancer Cell Proliferation Cancer Res., October 1, 2003; 63(19): 6413 - 6423. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hui, G. L. Finney, J. S. Carroll, C. S. L. Lee, E. A. Musgrove, and R. L. Sutherland Constitutive Overexpression of Cyclin D1 but not Cyclin E Confers Acute Resistance to Antiestrogens in T-47D Breast Cancer Cells Cancer Res., December 1, 2002; 62(23): 6916 - 6923. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Terry, M. D. Gammon, J. B. Schoenberg, L. A. Brinton, N. Arber, and H. Hibshoosh Oral Contraceptive Use and Cyclin D1 Overexpression in Breast Cancer among Young Women Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1100 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marino, F. Acconcia, F. Bresciani, A. Weisz, and A. Trentalance Distinct Nongenomic Signal Transduction Pathways Controlled by 17beta -Estradiol Regulate DNA Synthesis and Cyclin D1 Gene Transcription in HepG2 Cells Mol. Biol. Cell, October 1, 2002; 13(10): 3720 - 3729. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Abdelrahim, I. Samudio, R. Smith III, R. Burghardt, and S. Safe Small Inhibitory RNA Duplexes for Sp1 mRNA Block Basal and Estrogen-induced Gene Expression and Cell Cycle Progression in MCF-7 Breast Cancer Cells J. Biol. Chem., August 2, 2002; 277(32): 28815 - 28822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Carroll, A. Swarbrick, E. A. Musgrove, and R. L. Sutherland Mechanisms of Growth Arrest by c-myc Antisense Oligonucleotides in MCF-7 Breast Cancer Cells: Implications for the Antiproliferative Effects of Antiestrogens Cancer Res., June 1, 2002; 62(11): 3126 - 3131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Skildum, S. Mukherjee, and S. E. Conrad The Cyclin-dependent Kinase Inhibitor p21WAF1/Cip1 Is an Antiestrogen-regulated Inhibitor of Cdk4 in Human Breast Cancer Cells J. Biol. Chem., February 8, 2002; 277(7): 5145 - 5152. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Kovacs, A. Oszter, P. M. Gocze, J. L. Kornyei, and I. Szabo Comparative analysis of cyclin D1 and oestrogen receptor ({alpha} and {beta}) levels in human leiomyoma and adjacent myometrium Mol. Hum. Reprod., November 1, 2001; 7(11): 1085 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Planas-Silva, Y. Shang, J. L. Donaher, M. Brown, and R. A. Weinberg AIB1 Enhances Estrogen-dependent Induction of Cyclin D1 Expression Cancer Res., May 1, 2001; 61(10): 3858 - 3862. [Abstract] [Full Text] |
||||
![]() |
D. Manole, B. Schildknecht, B. Gosnell, E. Adams, and M. Derwahl Estrogen Promotes Growth of Human Thyroid Tumor Cells by Different Molecular Mechanisms J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1072 - 1077. [Abstract] [Full Text] |
||||
![]() |
I. Samudio, C. Vyhlidal, F. Wang, M. Stoner, I. Chen, M. Kladde, R. Barhoumi, R. Burghardt, and S. Safe Transcriptional Activation of Deoxyribonucleic Acid Polymerase {{alpha}} Gene Expression in MCF-7 Cells by 17{{beta}}-Estradiol Endocrinology, March 1, 2001; 142(3): 1000 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Foster, D. C. Henley, A. Bukovsky, P. Seth, and J. Wimalasena Multifaceted Regulation of Cell Cycle Progression by Estrogen: Regulation of Cdk Inhibitors and Cdc25A Independent of Cyclin D1-Cdk4 Function Mol. Cell. Biol., February 1, 2001; 21(3): 794 - 810. [Abstract] [Full Text] |
||||
![]() |
D.-Z. J. Liao, X. Hou, S. Bai, S. Antonia Li, and J. J. Li Unusual deregulation of cell cycle components in early and frank estrogen-induced renal neoplasias in the Syrian hamster Carcinogenesis, December 1, 2000; 21(12): 2167 - 2173. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xie, R. Duan, I. Chen, I. Samudio, and S. Safe Transcriptional Activation of Thymidylate Synthase by 17{beta}-Estradiol in MCF-7 Human Breast Cancer Cells Endocrinology, July 1, 2000; 141(7): 2439 - 2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hui, R. D. Macmillan, F. S. Kenny, E. A. Musgrove, R. W. Blamey, R. I. Nicholson, J. F. R. Robertson, and R. L. Sutherland INK4a Gene Expression and Methylation in Primary Breast Cancer: Overexpression of p16INK4a Messenger RNA Is a Marker of Poor Prognosis Clin. Cancer Res., July 1, 2000; 6(7): 2777 - 2787. [Abstract] [Full Text] |
||||
![]() |
A. M. Molinari, P. Bontempo, E. M. Schiavone, V. Tortora, M. A. Verdicchio, M. Napolitano, E. Nola, B. Moncharmont, N. Medici, V. Nigro, et al. Estradiol Induces Functional Inactivation of p53 by Intracellular Redistribution Cancer Res., May 1, 2000; 60(10): 2594 - 2597. [Abstract] [Full Text] |
||||
![]() |
E. K. Lobenhofer, G. Huper, J. D. Iglehart, and J. R. Marks Inhibition of Mitogen-activated Protein Kinase and Phosphatidylinositol 3-Kinase Activity in MCF-7 Cells Prevents Estrogen-induced Mitogenesis Cell Growth Differ., February 1, 2000; 11(2): 99 - 110. [Abstract] [Full Text] |
||||
![]() |
G. Barrera-Hernandez, K. S. Park, A. Dace, Q. Zhan, and S.-y. Cheng Thyroid Hormone-Induced Cell Proliferation in GC Cells Is Mediated by Changes in G1 Cyclin/Cyclin-Dependent Kinase Levels and Activity Endocrinology, November 1, 1999; 140(11): 5267 - 5274. [Abstract] [Full Text] |
||||
![]() |
A. Orimo, S. Inoue, O. Minowa, N. Tominaga, Y. Tomioka, M. Sato, J. Kuno, H. Hiroi, Y. Shimizu, M. Suzuki, et al. Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha PNAS, October 12, 1999; 96(21): 12027 - 12032. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Planas-Silva, J. L. Donaher, and R. A. Weinberg Functional Activity of Ectopically Expressed Estrogen Receptor Is Not Sufficient for Estrogen-mediated Cyclin D1 Expression Cancer Res., October 1, 1999; 59(19): 4788 - 4792. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Pestell, C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation Endocr. Rev., August 1, 1999; 20(4): 501 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, L. Dong, B. Saville, and S. Safe Transcriptional Activation of E2F1 Gene Expression by 17{beta}-Estradiol in MCF-7 Cells Is Regulated by NF-Y-Sp1/Estrogen Receptor Interactions Mol. Endocrinol., August 1, 1999; 13(8): 1373 - 1387. [Abstract] [Full Text] |
||||
![]() |
F. S. Kenny, R. Hui, E. A. Musgrove, J. M.W. Gee, R. W. Blamey, R. I. Nicholson, R. L. Sutherland, and J. F. R. Robertson Overexpression of Cyclin D1 Messenger RNA Predicts for Poor Prognosis in Estrogen Receptor-positive Breast Cancer Clin. Cancer Res., August 1, 1999; 5(8): 2069 - 2076. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. W. J. Prall, E. M. Rogan, E. A. Musgrove, C. K. W. Watts, and R. L. Sutherland c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry Mol. Cell. Biol., August 1, 1998; 18(8): 4499 - 4508. [Abstract] [Full Text] |
||||
![]() |
R. L. Robker and J. S. Richards Hormone-Induced Proliferation and Differentiation of Granulosa Cells: A Coordinated Balance of the Cell Cycle Regulators Cyclin D2 and p27Kip1 Mol. Endocrinol., July 1, 1998; 12(7): 924 - 940. [Abstract] [Full Text] |
||||
![]() |
R. L. Robker and J. S. Richards Hormonal Control of the Cell Cycle in Ovarian Cells: Proliferation Versus Differentiation Biol Reprod, July 1, 1998; 59(3): 476 - 482. [Full Text] |
||||
![]() |
E. A. Musgrove, A. Swarbrick, C. S. L. Lee, A. L. Cornish, and R. L. Sutherland Mechanisms of Cyclin-Dependent Kinase Inactivation by Progestins Mol. Cell. Biol., April 1, 1998; 18(4): 1812 - 1825. [Abstract] [Full Text] |
||||
![]() |
R.-s. Ge and M. P. Hardy Decreased Cyclin A2 and Increased Cyclin G1 Levels Coincide with Loss of Proliferative Capacity in Rat Leydig Cells During Pubertal Development Endocrinology, September 1, 1997; 138(9): 3719 - 3726. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Said, O. M. Conneely, D. Medina, B. W. O'Malley, and J. P. Lydon Progesterone, in Addition to Estrogen, Induces Cyclin D1 Expression in the Murine Mammary Epithelial Cell, in Vivo Endocrinology, September 1, 1997; 138(9): 3933 - 3939. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Teixeira and M. A. C. Pratt CDK2 Is a Target for Retinoic Acid-Mediated Growth Inhibition in MCF-7 Human Breast Cancer Cells Mol. Endocrinol., August 1, 1997; 11(9): 1191 - 1202. [Abstract] [Full Text] |
||||
![]() |
O. W.J. Prall, B. Sarcevic, E. A. Musgrove, C. K.W. Watts, and R. L. Sutherland Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2 J. Biol. Chem., April 18, 1997; 272(16): 10882 - 10894. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Altucci, R. Addeo, L. Cicatiello, D. Germano, C. Pacilio, T. Battista, M. Cancemi, V. B. Petrizzi, F. Bresciani, and A. Weisz Estrogen Induces Early and Timed Activation of Cyclin-Dependent Kinases 4, 5, and 6 and Increases Cyclin Messenger Ribonucleic Acid Expression in Rat Uterus Endocrinology, March 1, 1997; 138(3): 978 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Musgrove, C. S. L. Lee, A. L. Cornish, A. Swarbrick, and R. L. Sutherland Antiprogestin Inhibition of Cell Cycle Progression in T-47D Breast Cancer Cells Is Accompanied by Induction of the Cyclin-Dependent Kinase Inhibitor p21 Mol. Endocrinol., January 1, 1997; 11(1): 54 - 66. [Abstract] [Full Text] |
||||
![]() |
J. S. Carroll, O. W. J. Prall, E. A. Musgrove, and R. L. Sutherland A Pure Estrogen Antagonist Inhibits Cyclin E-Cdk2 Activity in MCF-7 Breast Cancer Cells and Induces Accumulation of p130-E2F4 Complexes Characteristic of Quiescence J. Biol. Chem., December 1, 2000; 275(49): 38221 - 38229. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dupont, M. Karas, and D. LeRoith The Potentiation of Estrogen on Insulin-like Growth Factor I Action in MCF-7 Human Breast Cancer Cells Includes Cell Cycle Components J. Biol. Chem., November 10, 2000; 275(46): 35893 - 35901. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lai, B. Sarcevic, O. W. J. Prall, and R. L. Sutherland Insulin/Insulin-like Growth Factor-I and Estrogen Cooperate to Stimulate Cyclin E-Cdk2 Activation and Cell Cycle Progression in MCF-7 Breast Cancer Cells through Differential Regulation of Cyclin E and p21WAF1/Cip1 J. Biol. Chem., July 6, 2001; 276(28): 25823 - 25833. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Castro-Rivera, I. Samudio, and S. Safe Estrogen Regulation of Cyclin D1 Gene Expression in ZR-75 Breast Cancer Cells Involves Multiple Enhancer Elements J. Biol. Chem., August 10, 2001; 276(33): 30853 - 30861. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Urban, T. Golden, I. V. Aragon, J. G. Scammell, N. M. Dean, and R. E. Honkanen Identification of an Estrogen-inducible Phosphatase (PP5) That Converts MCF-7 Human Breast Carcinoma Cells into an Estrogen-independent Phenotype when Expressed Constitutively J. Biol. Chem., July 13, 2001; 276(29): 27638 - 27646. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. W. J. Prall, J. S. Carroll, and R. L. Sutherland A Low Abundance Pool of Nascent p21WAF1/Cip1 Is Targeted by Estrogen to Activate Cyclin E{middle dot}Cdk2 J. Biol. Chem., November 21, 2001; 276(48): 45433 - 45442. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cariou, J. C. H. Donovan, W. M. Flanagan, A. Milic, N. Bhattacharya, and J. M. Slingerland Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells PNAS, August 1, 2000; 97(16): 9042 - 9046. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |